| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.61 | -0.05 (-8.13%) | 0.60 - 1.37 | 2.0 thousand (Above Avg) |
Market data as of 9:38AM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 0.62 |
|---|---|
| Previous Close | 0.66 |
| Day's Range | 0.60 - 0.62 |
| Market Cap | 8.3M |
| Avg Volume (10 Day) | 19.1K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.21 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ
PR Newswire - Friday 05/10/2013 5:00 PM ET
| CJJD | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 10.88% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.14 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 0.09 |
| Company | Last | Change |
|---|---|---|
| China Nepstar Chain Drugstore Ltd | 1.71 | -1.16% |
| PharMerica Corp | 14.40 | +2.13% |
| Rite Aid Corp | 2.86 | -2.05% |
| GNC Holdings Inc | 45.52 | -0.02% |
| Walgreen Co | 50.20 | -0.40% |
Data is delayed by at least 15 min.